TOOsonix Collaborates with Consultronix to Bring Advanced Dermatology Solutions to Poland

TOOsonix and Consultronix Join Forces in Poland

TOOsonix, renowned for its cutting-edge dermatological therapy devices, has recently announced a significant partnership with Consultronix, a key player in distributing advanced medical technologies in Poland. This collaboration aims to introduce TOOsonix's state-of-the-art focused ultrasound skin therapy, offering healthcare professionals innovative solutions for treating various skin diseases.

The Impact of the Partnership

The introduction of the TOOsonix System ONE-M in Poland is poised to change the landscape of dermatological treatment across the country. This device is classified as a MDR Class IIa CE-marked medical device, which employs focused ultrasound technology to effectively treat a wide range of skin conditions, including non-melanoma skin cancers, pre-cancerous lesions, and various aesthetic issues. The significance of this partnership lies not only in the technology itself but also in its timing; approximately 20% of Poland’s population is aged 65 and over, a demographic that commonly suffers from age-related skin conditions.

Innovative Treatment Solutions

The TOOsonix System ONE-M stands out due to its non-invasive approach. The treatment process is straightforward, involving a handpiece that directly contacts the targeted lesion. Healthcare professionals can activate focused ultrasound doses, allowing for high-resolution monitoring of the treatment in real-time from the system screen. This technology eliminates the need for anesthesia and minimizes downtime for patients, making it an efficient option for both medical and aesthetic dermatological treatments.

Addressing the Needs of Polish Patients

Poland’s healthcare landscape is undergoing a transformation, and the partnership with Consultronix is a strategic move to enhance the quality of care in the region. With their extensive experience and well-established relationships with dermatology clinics and hospitals throughout the country, Consultronix is uniquely positioned to facilitate the successful introduction of TOOsonix products. This partnership, according to Piotr Smolarski, CEO of Consultronix, aligns perfectly with their mission to provide Polish healthcare professionals with the best tools to meet evolving patient needs.

Comments from Leadership

Torsten Bove and Tomasz Zawada, the founders of TOOsonix, expressed their enthusiasm about expanding their reach into the Central European market. They emphasized Consultronix’s reputation for quality and understanding of the local healthcare dynamics as vital components of this collaboration. The combination of TOOsonix’s innovative technology and Consultronix’s distribution capabilities is expected to lead to improved patient outcomes across Poland.

A Step Further in TOOsonix's Expansion Strategy

This partnership not only signifies TOOsonix's commitment to expanding its footprint in Europe but also reinforces its dedication to making advanced dermatological therapies accessible to more patients globally. The collaboration is seen as a significant milestone in TOOsonix's international expansion strategy, paving the way for the introduction of groundbreaking therapies that can address pressing dermatological concerns in various populations.

About the Companies

TOOsonix is at the forefront of high-intensity focused ultrasound technology, specializing in treatments for cancerous, pre-cancerous, and benign skin conditions. By actively collaborating with healthcare professionals across Europe and the United States, they strive to deliver safe, effective solutions for skin care.

Consultronix, after 38 years in the industry, has established itself as a trusted partner for healthcare professionals in Poland, focusing on innovation and customer satisfaction in medical device distribution. Their commitment to quality and patient care is evident in their collaboration with TOOsonix.

In conclusion, the partnership between TOOsonix and Consultronix represents a promising evolution in dermatological care within Poland, aimed at providing new, effective solutions for skin-related ailments that many individuals face, especially in the aging population.